Castle Biosciences Inc. (CSTL) Reports In-Line Q1 EPS

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q1 EPS of ($0.49), in-line with the analyst estimate of ($0.49). Revenue for the quarter came in at $83.7 million versus the consensus estimate of $77.46 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• Ingram Micro Holding Corporation (INGM) Tops Q2 EPS by 4c
• Alignment Healthcare, Inc. (ALHC) Tops Q2 EPS by 4c; offers guidance
• GSI Technology (GSIT) Reports Q1 Loss of $0.13